Holarrhena antidysenterica with Black seed and Cicer arietinum
Holarrhena antidysenterica with Black seed and Cicer arietinum, NPN 80130484: natural health product licensed in Canada. Medicinal ingredients: Prunus dulcis, Cicer arietinum, Nigella sativa, Holarrhena pubescens.
If this product were sold in France
- Legal conditions
Nigella sativa L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les enfants, adolescents, femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Prunus dulcis Source : Prunus dulcis - Graine | 125 mg | Not calculated |
| Cicer arietinum Source : Cicer arietinum - seed | 125 mg | Not calculated |
| Nigella sativa | 125 mg | Not calculated |
| Holarrhena pubescens | 125 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contra-Indications
Do not use if you are pregnant.
Product record
- Other names
- Metabo 101
- Licence holder
- Creatrixe Solutions Limited
- NPN or DIN-HM
- 80130484
- Status
- Active licence
- Licence date
- 9 April 2024
- Revision date
- 17 September 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80130484
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Holarrhena antidysenterica with Black seed and Cicer arietinum (Creatrixe Solutions Limited): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80130484-holarrhena-antidysenterica-with-black-seed-and-cicer-arietin, updated 17 September 2025.